After $371 Million Merger, What's Next for LabCorp and Sequenom?
On Thursday, when the genetic testing lab Sequenom called off its regular earnings call, investors might have worried about the reason for the cancellation. That is, if they missed the news that Laboratory Corp. of America had agreed to buy Sequenom for $371 million.
Either way, the question now is what comes next for the two companies that are perched on a risky, competitive genetic testing market valued in 2015 at $3 billion.
First off, the closing of the acquisition should happen by the end of 2016, LabCorp spokeswoman Pattie Kushner said, assuming regulators sign off on the deal.
Either way, the question now is what comes next for the two companies that are perched on a risky, competitive genetic testing market valued in 2015 at $3 billion.
First off, the closing of the acquisition should happen by the end of 2016, LabCorp spokeswoman Pattie Kushner said, assuming regulators sign off on the deal.